SLXN
Price
$2.47
Change
-$0.10 (-3.89%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
8.04M
Intraday BUY SELL Signals
VRTX
Price
$421.00
Change
-$14.52 (-3.33%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
110.5B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SLXN vs VRTX

Header iconSLXN vs VRTX Comparison
Open Charts SLXN vs VRTXBanner chart's image
Silexion Therapeutics
Price$2.47
Change-$0.10 (-3.89%)
Volume$322
Capitalization8.04M
Vertex Pharmaceuticals
Price$421.00
Change-$14.52 (-3.33%)
Volume$26.67K
Capitalization110.5B
SLXN vs VRTX Comparison Chart in %
SLXN
Daily Signal:
Gain/Loss:
VRTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SLXN vs. VRTX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a Hold and VRTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (SLXN: $2.57 vs. VRTX: $435.52)
Brand notoriety: SLXN and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 12% vs. VRTX: 71%
Market capitalization -- SLXN: $8.04M vs. VRTX: $110.5B
SLXN [@Biotechnology] is valued at $8.04M. VRTX’s [@Biotechnology] market capitalization is $110.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 2 green FA rating(s).

  • SLXN’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • SLXN’s TA Score: 5 bullish, 3 bearish.
  • VRTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than VRTX.

Price Growth

SLXN (@Biotechnology) experienced а -8.54% price change this week, while VRTX (@Biotechnology) price change was +1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

VRTX is expected to report earnings on Feb 04, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($110B) has a higher market cap than SLXN($8.04M). VRTX has higher P/E ratio than SLXN: VRTX (30.65) vs SLXN (0.01). VRTX YTD gains are higher at: 8.150 vs. SLXN (-91.476). VRTX has higher annual earnings (EBITDA): 4.59B vs. SLXN (-17.81M). VRTX has more cash in the bank: 6.38B vs. SLXN (3.47M). SLXN has less debt than VRTX: SLXN (3.7M) vs VRTX (1.53B). VRTX has higher revenues than SLXN: VRTX (11.4B) vs SLXN (0).
SLXNVRTXSLXN / VRTX
Capitalization8.04M110B0%
EBITDA-17.81M4.59B-0%
Gain YTD-91.4768.150-1,122%
P/E Ratio0.0130.650%
Revenue011.4B-
Total Cash3.47M6.38B0%
Total Debt3.7M1.53B0%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLXNVRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
47%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bearish Trend 6 days ago
29%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 8 days ago
54%
Bullish Trend 6 days ago
59%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 13 days ago
40%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signal:
Gain/Loss:
VRTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZH20.000.09
+0.45%
Beazer Homes USA
CELZ3.05N/A
N/A
Creative Medical Technology Holdings
GMAB30.32-0.10
-0.33%
Genmab A/S ADS
COLM51.16-0.29
-0.56%
Columbia Sportswear Company
KG14.26-0.64
-4.33%
Kestrel Group Ltd

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-0.39%
IMA - SLXN
62%
Loosely correlated
-1.30%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
-0.47%
CHRS - SLXN
26%
Poorly correlated
+7.08%
QSI - SLXN
25%
Poorly correlated
-2.31%
More